▶ 調査レポート

世界の慢性関節リウマチ（RA）薬市場：市場規模・現状・予測
• 英文タイトル：Global Rheumatoid Arthritis (RA) Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の慢性関節リウマチ（RA）薬市場：市場規模・現状・予測 / Global Rheumatoid Arthritis (RA) Drugs Market Size, Status and Forecast 2019-2025 / QYR9N7971資料のイメージです。• レポートコード：QYR9N7971
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、慢性関節リウマチ（RA）薬のグローバル市場について調査・分析したレポートで、種類別（経口、注入、外用）、用途別（医療、パーソナルケア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・慢性関節リウマチ（RA）薬の世界市場規模
・主要企業別市場シェア
・慢性関節リウマチ（RA）薬の世界市場規模：種類別（経口、注入、外用）
・慢性関節リウマチ（RA）薬の世界市場規模：用途別（医療、パーソナルケア）
・慢性関節リウマチ（RA）薬のアメリカ市場規模（種類別、用途別）
・慢性関節リウマチ（RA）薬のヨーロッパ市場規模（種類別、用途別）
・慢性関節リウマチ（RA）薬の中国市場規模（種類別、用途別）
・慢性関節リウマチ（RA）薬の日本市場規模（種類別、用途別）
・慢性関節リウマチ（RA）薬の東南アジア市場規模（種類別、用途別）
・慢性関節リウマチ（RA）薬のインド市場規模（種類別、用途別）
・慢性関節リウマチ（RA）薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・慢性関節リウマチ（RA）薬の世界市場予測（2019年-2025年）
・慢性関節リウマチ（RA）薬の地域別市場予測（2019年-2025年）
...

Rheumatoid arthritis (RA) is an inflammatory disease that progresses over time affecting the joints. The symptoms aggravate over time, which is why medication for RA becomes essential to stop the inflammation. There is no permanent cure for rheumatoid arthritis, though increasing research activities regarding the same indicate that remission of symptoms is achieved when treatment begins in the initial stages with strong medications known as disease-modifying antirheumatic drugs (DMARDs).In 2018, the global Rheumatoid Arthritis (RA) Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Rheumatoid Arthritis (RA) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rheumatoid Arthritis (RA) Drugs development in United States, Europe and China.

The key players covered in this study
AbbVie
Roche
Johnson & Johnson
Amgen, Inc.
Pfizer
Merck
Bristol-Myers Squibb
UCB
GlaxoSmithKline
Sanofi
Abbott Laboratories
Teva Pharmaceutical

Market segment by Type, the product can be split into
Oral
Injection
External

Market segment by Application, split into
Medical Care
Personal Care

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rheumatoid Arthritis (RA) Drugs status, future forecast, growth opportunity, key market and key players.
To present the Rheumatoid Arthritis (RA) Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rheumatoid Arthritis (RA) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Injection
1.4.4 External
1.5 Market by Application
1.5.1 Global Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2025)
1.5.2 Medical Care
1.5.3 Personal Care
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Rheumatoid Arthritis (RA) Drugs Market Size
2.2 Rheumatoid Arthritis (RA) Drugs Growth Trends by Regions
2.2.1 Rheumatoid Arthritis (RA) Drugs Market Size by Regions (2014-2025)
2.2.2 Rheumatoid Arthritis (RA) Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Rheumatoid Arthritis (RA) Drugs Market Size by Manufacturers
3.1.1 Global Rheumatoid Arthritis (RA) Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rheumatoid Arthritis (RA) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Rheumatoid Arthritis (RA) Drugs Key Players Head office and Area Served
3.3 Key Players Rheumatoid Arthritis (RA) Drugs Product/Solution/Service
3.4 Date of Enter into Rheumatoid Arthritis (RA) Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019)
4.2 Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Rheumatoid Arthritis (RA) Drugs Market Size (2014-2019)
5.2 Rheumatoid Arthritis (RA) Drugs Key Players in United States
5.3 United States Rheumatoid Arthritis (RA) Drugs Market Size by Type
5.4 United States Rheumatoid Arthritis (RA) Drugs Market Size by Application

6 Europe
6.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size (2014-2019)
6.2 Rheumatoid Arthritis (RA) Drugs Key Players in Europe
6.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type
6.4 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application

7 China
7.1 China Rheumatoid Arthritis (RA) Drugs Market Size (2014-2019)
7.2 Rheumatoid Arthritis (RA) Drugs Key Players in China
7.3 China Rheumatoid Arthritis (RA) Drugs Market Size by Type
7.4 China Rheumatoid Arthritis (RA) Drugs Market Size by Application

8 Japan
8.1 Japan Rheumatoid Arthritis (RA) Drugs Market Size (2014-2019)
8.2 Rheumatoid Arthritis (RA) Drugs Key Players in Japan
8.3 Japan Rheumatoid Arthritis (RA) Drugs Market Size by Type
8.4 Japan Rheumatoid Arthritis (RA) Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size (2014-2019)
9.2 Rheumatoid Arthritis (RA) Drugs Key Players in Southeast Asia
9.3 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size by Type
9.4 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size by Application

10 India
10.1 India Rheumatoid Arthritis (RA) Drugs Market Size (2014-2019)
10.2 Rheumatoid Arthritis (RA) Drugs Key Players in India
10.3 India Rheumatoid Arthritis (RA) Drugs Market Size by Type
10.4 India Rheumatoid Arthritis (RA) Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Rheumatoid Arthritis (RA) Drugs Market Size (2014-2019)
11.2 Rheumatoid Arthritis (RA) Drugs Key Players in Central & South America
11.3 Central & South America Rheumatoid Arthritis (RA) Drugs Market Size by Type
11.4 Central & South America Rheumatoid Arthritis (RA) Drugs Market Size by Application

12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.1.4 AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.2.4 Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Amgen, Inc.
12.4.1 Amgen, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.4.4 Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.4.5 Amgen, Inc. Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.5.4 Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.6.4 Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.7.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.7.5 Bristol-Myers Squibb Recent Development
12.8 UCB
12.8.1 UCB Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.8.4 UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.8.5 UCB Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.9.4 GlaxoSmithKline Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.9.5 GlaxoSmithKline Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.10.4 Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
12.10.5 Sanofi Recent Development
12.11 Abbott Laboratories
12.12 Teva Pharmaceutical

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Rheumatoid Arthritis (RA) Drugs Key Market Segments
Table Key Players Rheumatoid Arthritis (RA) Drugs Covered
Table Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type 2014-2025
Figure Oral Figures
Table Key Players of Oral
Figure Injection Figures
Table Key Players of Injection
Figure External Figures
Table Key Players of External
Table Global Rheumatoid Arthritis (RA) Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Medical Care Case Studies
Figure Personal Care Case Studies
Figure Rheumatoid Arthritis (RA) Drugs Report Years Considered
Table Global Rheumatoid Arthritis (RA) Drugs Market Size 2014-2025 (Million US$)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Rheumatoid Arthritis (RA) Drugs Market Share by Regions 2014-2019
Figure Global Rheumatoid Arthritis (RA) Drugs Market Share by Regions 2014-2019
Figure Global Rheumatoid Arthritis (RA) Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Rheumatoid Arthritis (RA) Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Rheumatoid Arthritis (RA) Drugs Market Share by Manufacturers (2014-2019)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Share by Manufacturers in 2018
Table Global Rheumatoid Arthritis (RA) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rheumatoid Arthritis (RA) Drugs Product/Solution/Service
Table Date of Enter into Rheumatoid Arthritis (RA) Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Rheumatoid Arthritis (RA) Drugs Market Size Share by Type (2014-2019)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type (2014-2019)
Table Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Rheumatoid Arthritis (RA) Drugs Market Size Share by Application (2014-2019)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application (2014-2019)
Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application in 2018
Figure United States Rheumatoid Arthritis (RA) Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Rheumatoid Arthritis (RA) Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Rheumatoid Arthritis (RA) Drugs Market Share (2018-2019)
Table United States Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Rheumatoid Arthritis (RA) Drugs Market Share by Type (2014-2019)
Table United States Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2019)
Figure Europe Rheumatoid Arthritis (RA) Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Rheumatoid Arthritis (RA) Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Rheumatoid Arthritis (RA) Drugs Market Share (2018-2019)
Table Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Rheumatoid Arthritis (RA) Drugs Market Share by Type (2014-2019)
Table Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2019)
Figure China Rheumatoid Arthritis (RA) Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Rheumatoid Arthritis (RA) Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Rheumatoid Arthritis (RA) Drugs Market Share (2018-2019)
Table China Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-20189) (Million US$)
Table China Rheumatoid Arthritis (RA) Drugs Market Share by Type (2014-2019)
Table China Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table China Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2019)
Figure Japan Rheumatoid Arthritis (RA) Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Rheumatoid Arthritis (RA) Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Rheumatoid Arthritis (RA) Drugs Market Share (2018-2019)
Table Japan Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Rheumatoid Arthritis (RA) Drugs Market Share by Type (2014-2019)
Table Japan Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Rheumatoid Arthritis (RA) Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Rheumatoid Arthritis (RA) Drugs Market Share (2018-2019)
Table Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Share by Type (2014-2019)
Table Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2019)
Figure India Rheumatoid Arthritis (RA) Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Rheumatoid Arthritis (RA) Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Rheumatoid Arthritis (RA) Drugs Market Share (2018-2019)
Table India Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019) (Million US$)
Table India Rheumatoid Arthritis (RA) Drugs Market Share by Type (2014-2019)
Table India Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table India Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2019)
Figure Central & South America Rheumatoid Arthritis (RA) Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Rheumatoid Arthritis (RA) Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Rheumatoid Arthritis (RA) Drugs Market Share (2018-2019)
Table Central & South America Rheumatoid Arthritis (RA) Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Rheumatoid Arthritis (RA) Drugs Market Share by Type (2014-2019)
Table Central & South America Rheumatoid Arthritis (RA) Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Rheumatoid Arthritis (RA) Drugs Market Share by Application (2014-2019)
Table AbbVie Company Details
Table AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019) (Million US$)
Figure AbbVie Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Roche Company Details
Table Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table Roche Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Amgen, Inc. Company Details
Table Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure Amgen, Inc. Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table Amgen, Inc. Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table Merck Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table UCB Company Details
Table UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure UCB Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table UCB Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Abbott Laboratories Company Details
Table Teva Pharmaceutical Company Details
Table Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size Share by Regions (2019-2025)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size Share by Regions in 2025
Figure United States Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Rheumatoid Arthritis (RA) Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size by Product (2019-2025)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size by Product in 2025
Table Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2019-2025)
Figure Global Rheumatoid Arthritis (RA) Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の慢性関節リウマチの治療市場：市場規模・現状・予測
    Global Rheumatoid Arthritis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7973 2019年6月14日 98Pages
    当資料は、慢性関節リウマチの治療のグローバル市場について調査・分析したレポートで、種類別（対症療法、中間コルチコステロイド療法、疾患修飾性抗リウマチ薬療法）、用途別（病院薬局、小売薬局、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、...
  • 世界の慢性関節リウマチ診断テスト市場：市場規模・現状・予測
    Global Rheumatoid Arthritis Diagnosis Tests Market Size, Status and Forecast 2019-2025
    QYR9N7972 2019年6月14日 93Pages
    当資料は、慢性関節リウマチ診断テストのグローバル市場について調査・分析したレポートで、種類別（血清学テスト、RA治療効率試験のモニタリング）、用途別（診断研究所、外来手術センター、病院）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界の敗血症性関節炎市場：市場規模・現状・予測
    Global Septic Arthritis Market Size, Status and Forecast 2019-2025
    QYR9N8019 2019年6月14日 92Pages
    当資料は、敗血症性関節炎のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（整形外科病院、診療所、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ...
  • 世界の敗血症性関節炎の治療市場：市場規模・現状・予測
    Global Septic Arthritis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8020 2019年6月14日 90Pages
    当資料は、敗血症性関節炎の治療のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（整形外科病院、診療所、診断センター、病院）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    <...
  • 世界の乾癬性関節炎治療市場：市場規模・現状・予測
    Global Psoriatic Arthritis Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7904 2019年6月14日 96Pages
    当資料は、乾癬性関節炎治療のグローバル市場について調査・分析したレポートで、種類別（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ薬、生物学的薬剤、酵素阻害剤）、用途別（病院、診療所、研究室）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報...
  • 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測
    Global Myelodysplastic Syndrome (MDS) Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7611 2019年6月14日 96Pages
    当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界のうつ病薬市場：市場規模・現状・予測
    Global Depression Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7085 2019年6月14日 98Pages
    当資料は、うつ病薬のグローバル市場について調査・分析したレポートで、種類別（SSRI、SNRI、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・う...
  • 世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測
    Global Non Cataplexy Narcolepsy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7681 2019年6月14日 93Pages
    当資料は、非カタプレキシーナルコレプシー薬のグローバル市場について調査・分析したレポートで、種類別（抗酸化薬、覚せい剤、その他）、用途別（子供（18歳未満）、成人（18〜50歳）、高齢者（50歳以上）、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...
  • 世界の凍結乾燥注射薬市場：市場規模・現状・予測
    Global Lyophilized Injectable Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7487 2019年6月14日 96Pages
    当資料は、凍結乾燥注射薬のグローバル市場について調査・分析したレポートで、種類別（使い捨てバイアル、ポイントオブケア再構成、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のテネクテプラーゼ薬市場：市場規模・現状・予測
    Global Tenecteplase Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8112 2019年6月14日 93Pages
    当資料は、テネクテプラーゼ薬のグローバル市場について調査・分析したレポートで、種類別（静脈内投与量、カテーテル内点滴注入量）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...